Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Buckner

Showing results (211-220 of 255) with videos related to

Pageof 26
Sort By:
Journal of Neuro-Oncology|May 24, 2019
Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)Kurt A Jaeckle, S K Anderson, Erin L Twohy, et al.
Journal of Neuro-Oncology|February 24, 2001
A randomized phase II and pharmacokinetic study of dacarbazine in patients with recurrent gliomaS V Rajkumar, J M Reid, P J Novotny, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2010
Combination of temsirolimus (CCI-779) with chemoradiation in newly diagnosed glioblastoma multiforme (GBM) (NCCTG trial N027D) is associated with increased infectious risksJann N Sarkaria, Eva Galanis, Wenting Wu, et al.
Molecular Phylogenetics and Evolution|March 17, 2018
A phylogenomic perspective on the robust capuchin monkey (Sapajus) radiation: First evidence for extensive population admixture across South AmericaMarcela G M Lima, José de Sousa E Silva-Júnior, David Černý, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2004
Adult patients with supratentorial pilocytic astrocytomas: a prospective multicenter clinical trialPaul D Brown, Jan C Buckner, Judith R O'Fallon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDHJ Gregory Cairncross, Meihua Wang, Robert B Jenkins, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 2010
Phase II evaluation of gefitinib in patients with newly diagnosed Grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074Joon H Uhm, Karla V Ballman, Wenting Wu, et al.
Neuro-Oncology|February 1, 2020
Final report from Intergroup NCCTG 86-72-51 (Alliance): a phase III randomized clinical trial of high-dose versus low-dose radiation for adult low-grade gliomaWilliam G Breen, S Keith Anderson, Xiomara W Carrero, et al.
Cancer|January 10, 2018
Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572David Schiff, Kurt A Jaeckle, S Keith Anderson, et al.
Journal of Virology|May 18, 2001
The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable regionS W Barnett, S Lu, I Srivastava, et al.
Pageof 26

Showing results (211-220 of 255) with videos related to

Sort By:
Pageof 26
Journal of Neuro-Oncology|May 24, 2019
Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)Kurt A Jaeckle, S K Anderson, Erin L Twohy, et al.
Journal of Neuro-Oncology|February 24, 2001
A randomized phase II and pharmacokinetic study of dacarbazine in patients with recurrent gliomaS V Rajkumar, J M Reid, P J Novotny, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2010
Combination of temsirolimus (CCI-779) with chemoradiation in newly diagnosed glioblastoma multiforme (GBM) (NCCTG trial N027D) is associated with increased infectious risksJann N Sarkaria, Eva Galanis, Wenting Wu, et al.
Molecular Phylogenetics and Evolution|March 17, 2018
A phylogenomic perspective on the robust capuchin monkey (Sapajus) radiation: First evidence for extensive population admixture across South AmericaMarcela G M Lima, José de Sousa E Silva-Júnior, David Černý, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2004
Adult patients with supratentorial pilocytic astrocytomas: a prospective multicenter clinical trialPaul D Brown, Jan C Buckner, Judith R O'Fallon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDHJ Gregory Cairncross, Meihua Wang, Robert B Jenkins, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 2010
Phase II evaluation of gefitinib in patients with newly diagnosed Grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074Joon H Uhm, Karla V Ballman, Wenting Wu, et al.
Neuro-Oncology|February 1, 2020
Final report from Intergroup NCCTG 86-72-51 (Alliance): a phase III randomized clinical trial of high-dose versus low-dose radiation for adult low-grade gliomaWilliam G Breen, S Keith Anderson, Xiomara W Carrero, et al.
Cancer|January 10, 2018
Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572David Schiff, Kurt A Jaeckle, S Keith Anderson, et al.
Journal of Virology|May 18, 2001
The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable regionS W Barnett, S Lu, I Srivastava, et al.
Pageof 26